Another report documented that 71% of ES and 100% of synovial sarcoma patients were positive for c-kit; additionally, 29 and 64% of ES and synovial sarcoma patients showed strong and diffuse staining for c-kit, respectively (Table 1; Smithey et al., 2002). This evidence concerns the gene KIT and synovial sarcoma.